Vimarsana
Biggest News Aggregation in the World

Risperdal Consta News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Risperdal Consta. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Risperdal Consta Today - Breaking & Trending Today

Nevada Attorney General settles with Johnson and Johnson over Risperdal disclosure - Vimarsana News

Nevada Attorney General settles with Johnson and Johnson over Risperdal disclosure

Nevada Attorney General Catherine Cortez Masto announced Thursday that she and 36 other AGs reached a record $181 million settlement, the largest multi-state consumer protection settlement of its kind reached with a pharmaceutical company, with Janssen Pharmaceuticals, Inc., a subsidiary of Johnson and Johnson.

The Role of the Pharmacist in Long-Acting Injectable Therapies for Schizophrenia and Bipolar Disorder - Vimarsana News

The Role of the Pharmacist in Long-Acting Injectable Therapies for Schizophrenia and Bipolar Disorder

These therapies can improve treatment adherence for patients, especially for those with a history of poor or uncertain adherence.

"Hidden Valley Road" and Schizophrenia: Do Genes Tell the Story? - Vimarsana News

"Hidden Valley Road" and Schizophrenia: Do Genes Tell the Story?

The “genetics of mental disorders” story told in Kolker's "Hidden Valley Road" involves omission and misrepresentation of genetic research.

BioHarvest Sciences Inc. Appoints Dr. George Garibaldi to Its Scientific Board of Advisors - Vimarsana News

BioHarvest Sciences Inc. Appoints Dr. George Garibaldi to Its Scientific Board of Advisors

Dr. Garibaldi's 40 years of experience brings industry-leading pharmaceuticals development expertise to the Scientific Board of Advisors.His appointment demonstrates the company's resolve to leverage

Telepsychiatry Sessions Sufficient for Managing Schizophrenia - Vimarsana News

Telepsychiatry Sessions Sufficient for Managing Schizophrenia

'Clinics were very creative' during the pandemic, researcher says